mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics

Vivek P. Chavda; Shailvi Soni; Lalitkumar K. Vora; Shruti Soni; Avinash Khadela; Jinal Ajabiya; S. Louise Cosby

doi:10.3390/vaccines10122150

mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics

Vivek P. Chavda^*, Shailvi Soni, Lalitkumar K. Vora^*, Shruti Soni, Avinash Khadela, Jinal Ajabiya, S. Louise Cosby (Editor)

^*Corresponding author for this work

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Review article › peer-review

51 Citations (Scopus)

163 Downloads (Pure)

Abstract

An unheard mobilization of resources to find SARS-CoV-2 vaccines and therapies has been sparked by the COVID-19 pandemic. Two years ago, COVID-19’s launch propelled mRNA-based technologies into the public eye. Knowledge gained from mRNA technology used to combat COVID-19 is assisting in the creation of treatments and vaccines to treat existing illnesses and may avert pandemics in the future. Exploiting the capacity of mRNA to create therapeutic proteins to impede or treat a variety of illnesses, including cancer, is the main goal of the quickly developing, highly multidisciplinary field of biomedicine. In this review, we explore the potential of mRNA as a vaccine and therapeutic using current research findings.

Original language	English
Article number	2150
Number of pages	20
Journal	Vaccines
Volume	10
Issue number	12
Early online date	15 Dec 2022
DOIs	https://doi.org/10.3390/vaccines10122150
Publication status	Early online date - 15 Dec 2022

Keywords

Review
COVID-19
SARS-CoV-2
pandemic
virus outbreak
mRNA vaccine
therapeutics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/vaccines10122150Licence: CC BY

mRNA-based vaccines and therapeutics for COVID-19 and future pandemics
© 2022 The Authors. This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
Final published version, 2.66 MBLicence: CC BY

Cite this

@article{ddce6ec6d73745898f0bcb8c525f2bd3,

title = "mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics",

abstract = "An unheard mobilization of resources to find SARS-CoV-2 vaccines and therapies has been sparked by the COVID-19 pandemic. Two years ago, COVID-19{\textquoteright}s launch propelled mRNA-based technologies into the public eye. Knowledge gained from mRNA technology used to combat COVID-19 is assisting in the creation of treatments and vaccines to treat existing illnesses and may avert pandemics in the future. Exploiting the capacity of mRNA to create therapeutic proteins to impede or treat a variety of illnesses, including cancer, is the main goal of the quickly developing, highly multidisciplinary field of biomedicine. In this review, we explore the potential of mRNA as a vaccine and therapeutic using current research findings.",

keywords = "Review, COVID-19, SARS-CoV-2, pandemic, virus outbreak, mRNA vaccine, therapeutics",

author = "Chavda, {Vivek P.} and Shailvi Soni and Vora, {Lalitkumar K.} and Shruti Soni and Avinash Khadela and Jinal Ajabiya and Cosby, {S. Louise}",

year = "2022",

month = dec,

day = "15",

doi = "10.3390/vaccines10122150",

language = "English",

volume = "10",

journal = "Vaccines",

issn = "2076-393X",

publisher = "MDPI",

number = "12",

}

TY - JOUR

T1 - mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics

AU - Chavda, Vivek P.

AU - Soni, Shailvi

AU - Vora, Lalitkumar K.

AU - Soni, Shruti

AU - Khadela, Avinash

AU - Ajabiya, Jinal

A2 - Cosby, S. Louise

PY - 2022/12/15

Y1 - 2022/12/15

N2 - An unheard mobilization of resources to find SARS-CoV-2 vaccines and therapies has been sparked by the COVID-19 pandemic. Two years ago, COVID-19’s launch propelled mRNA-based technologies into the public eye. Knowledge gained from mRNA technology used to combat COVID-19 is assisting in the creation of treatments and vaccines to treat existing illnesses and may avert pandemics in the future. Exploiting the capacity of mRNA to create therapeutic proteins to impede or treat a variety of illnesses, including cancer, is the main goal of the quickly developing, highly multidisciplinary field of biomedicine. In this review, we explore the potential of mRNA as a vaccine and therapeutic using current research findings.

AB - An unheard mobilization of resources to find SARS-CoV-2 vaccines and therapies has been sparked by the COVID-19 pandemic. Two years ago, COVID-19’s launch propelled mRNA-based technologies into the public eye. Knowledge gained from mRNA technology used to combat COVID-19 is assisting in the creation of treatments and vaccines to treat existing illnesses and may avert pandemics in the future. Exploiting the capacity of mRNA to create therapeutic proteins to impede or treat a variety of illnesses, including cancer, is the main goal of the quickly developing, highly multidisciplinary field of biomedicine. In this review, we explore the potential of mRNA as a vaccine and therapeutic using current research findings.

KW - Review

KW - COVID-19

KW - SARS-CoV-2

KW - pandemic

KW - virus outbreak

KW - mRNA vaccine

KW - therapeutics

U2 - 10.3390/vaccines10122150

DO - 10.3390/vaccines10122150

M3 - Review article

SN - 2076-393X

VL - 10

JO - Vaccines

JF - Vaccines

IS - 12

M1 - 2150

ER -

mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this